GAM Holding AG - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 154 filers reported holding REATA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
GAM Holding AG ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$764,000
-7.3%
25,1460.0%0.05%
+24.4%
Q1 2022$824,000
+24.3%
25,1460.0%0.04%
+36.7%
Q4 2021$663,000
-75.6%
25,146
-6.7%
0.03%
-76.2%
Q3 2021$2,712,000
-28.9%
26,9590.0%0.13%
-23.6%
Q2 2021$3,816,000
+23.1%
26,959
-13.3%
0.16%
+14.6%
Q1 2021$3,101,000
-52.3%
31,100
-53.4%
0.14%
-63.2%
Q3 2020$6,503,000
-37.6%
66,7500.0%0.39%
-39.6%
Q2 2020$10,414,000
+8.1%
66,7500.0%0.65%
-1.2%
Q1 2020$9,635,000
-33.9%
66,750
-6.3%
0.66%
-4.8%
Q4 2019$14,566,000
+99.3%
71,250
-21.7%
0.69%
+113.7%
Q3 2019$7,310,000
-14.9%
91,0500.0%0.32%
-4.2%
Q2 2019$8,591,000
+10.4%
91,0500.0%0.34%
+2.8%
Q1 2019$7,782,000
+150.4%
91,050
+64.4%
0.33%
+108.3%
Q4 2018$3,108,000
-30.4%
55,400
+1.5%
0.16%
-3.1%
Q3 2018$4,464,000
+176.9%
54,600
+18.4%
0.16%
+189.3%
Q2 2018$1,612,00046,1000.06%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
CPMG Inc 2,896,901$291,457,00032.14%
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 46,646$4,693,0005.31%
Ikarian Capital, LLC 471,400$47,423,0003.34%
Duquesne Family Office 695,033$69,927,0002.27%
Camber Capital Management LP 685,000$68,918,0002.12%
LBJ Family Wealth Advisors, Ltd. 30,359$3,054,0001.82%
MADDEN SECURITIES Corp 33,127$3,333,0001.80%
Biondo Investment Advisors, LLC 104,120$10,475,0001.80%
Tolleson Wealth Management, Inc. 60,750$6,112,0001.73%
Keel Point, LLC 97,074$9,767,0001.26%
View complete list of REATA PHARMACEUTICALS INC shareholders